Wolters Kluwer is Trusted Provider of Drug Information for Top-ranked USNWR's Best Children's Hospitals 2016-2017

Tuesday, August 9, 2016

August 9, 2016 – The Health division of Wolters Kluwer, a leading global provider of information and point of care solutions for the healthcare industry, is proud to provide vital drug information solutions to 97% of the Honor Roll Best Children’s Hospitals and the top 25 Best Hospitals for Pediatric Neonatology 2016-2017, as ranked by U.S. News & World Report (USNWR). The Clinical Drug Information unit of Wolters Kluwer supports safe medication practices and helps reduce drug-related errors at these eminent hospitals by connecting professionals to evidence-based and fully referenced pediatric- and neonatal-specific content, including dosing, precautions and alerts, preparations, pediatric considerations, and clinical practice guidelines.

USNWR determines its rankings from data collected through a clinical survey sent to 183 hospitals and a reputational survey sent to pediatric specialists. Among the criteria evaluated to select Honor Roll hospitals were: quality of nursing staff, infection prevention, maximizing positive clinical outcomes, coordination of care, and other specific criteria related to 10 specialties. Clinical Drug Information solutions are the choice of nearly all of this year’s 11 Honor Roll children’s hospitals and the top 25 of its 50 Honor Roll neonatology specialty departments.

Clinical Drug Information provides most of the highest ranked Honor Roll pediatric programs with industry-leading solutions to help them reduce medication errors and enhance the quality of care: * Lexicomp® - online drug references, mobile apps, customized formulary databases, and handbooks * Medi-Span® - EMR-integrated data to power clinical screening * Facts & Comparisons® – enhanced pharmacy content, online drug references, and handbooks

“We are beyond proud that so many of the nation’s best children’s hospitals trust us to help them safely care for these vulnerable populations,” said Denise Basow, MD, President & CEO of Clinical Effectiveness at Wolters Kluwer. “Clinical Drug Information’s goal is to help clinicians reduce harmful medication errors. By providing evidence-based content through our solutions, we’re able to help professionals feel confident treating even the smallest and youngest patients from day one.”

About Wolters Kluwer

Wolters Kluwer N.V. (AEX:WKL) is a global leader in information services and solutions for professionals in the health, tax and accounting, risk and compliance, finance and legal sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with specialized technology and services.

Wolters Kluwer reported 2015 annual revenues of €4.2 billion. The company, headquartered in Alphen aan den Rijn, the Netherlands, serves customers in over 180 countries, maintains operations in over 40 countries and employs 19,000 people worldwide.

Wolters Kluwer shares are listed on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).

Wolters Kluwer Health is a leading global provider of information and point of care solutions for the healthcare industry. For more information about our products and organization, visit http://www.wolterskluwer.com/, follow @WKHealth or @Wolters_Kluwer on Twitter, like us on Facebook, follow us on LinkedIn, or follow WoltersKluwerComms on YouTube.


Wolters Kluwer | Clinical Effectiveness
Meagan McCord, 330-650-6506
Manager, Marketing Communications, Clinical Drug Information